GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of GT Biopharma Inc..
GT Biopharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of GT Biopharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of GT Biopharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of GT Biopharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of GT Biopharma Inc. and all latest updates of the company are provided.
The 2025 version of GT Biopharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 GT Biopharma Inc.- Key Facts
2.2 GT Biopharma Inc.- Geographic Locations
2.3 GT Biopharma Inc.- Subsidiaries and Affiliates
2.4 GT Biopharma Inc.- Business Divisions
2.5 GT Biopharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. GT Biopharma Inc. Strategic Analysis Review
3.1 GT Biopharma Inc.- Key Strategies
3.2 GT Biopharma Inc.- Company Outlook Statement
3.3 GT Biopharma Inc.- SWOT Analysis
3.3.1 GT Biopharma Inc.- Key Strengths
3.3.2 GT Biopharma Inc.- Key Weaknesses
3.3.3 GT Biopharma Inc.- Potential Opportunities
3.3.4 GT Biopharma Inc.- Potential Threats
3.4 GT Biopharma Inc.- Key Competitors
4. Business Description of the Company
4.1 GT Biopharma Inc.- Business Overview
4.2 GT Biopharma Inc.- Operations by Segment
5 Products and Services Details
5.1 GT Biopharma Inc.- Key Products
5.2 GT Biopharma Inc.- Key Service Areas
5.3 GT Biopharma Inc.- Key Brands
6 Company Developments
6.1 GT Biopharma Inc.- Company History
6.2 GT Biopharma Inc.- Latest Developments
7 Financial Analysis
7.1 GT Biopharma Inc.- Income Statements
7.2 GT Biopharma Inc.- Balance Sheet
7.3 GT Biopharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 GT Biopharma Inc.- Direct Competitors
8.2 GT Biopharma Inc.- Competitor Financial Ratios comparison
8.3 GT Biopharma Inc.- Competitor Stock Charts Comparison
8.4 GT Biopharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
